Apollo Hospitals Enterprise shares rallied 4% to hit their 52-week high of ₹8,388 per share on Thursday, May 21, as the company's March quarter earnings boosted investor confidence. According to reports from The Economic Times, the healthcare-providing firm reported a consolidated net profit of ₹529 crore for the fourth quarter of FY26, marking an increase of 36% from ₹390 crore in the same period last year. The company's revenue from operations grew 18% to ₹6,606 crore in the January-March quarter compared to ₹5,592 crore in the corresponding quarter of the previous fiscal year. As per The Economic Times, the profit after tax (PAT) is attributable to the owners of the parent, with the company also posting 5.4% sequential growth from ₹502 crore in Q3FY26 and 2% quarter-on-quarter growth compared to ₹6,477 crore in Q3FY26.
The Chennai-headquartered company demonstrated strong operational performance with EBITDA advancing 31% to ₹1,011 crore as against ₹770 crore year-on-year. As reported by The Economic Times, the company's operating profit margin expanded to 15.3% annually from 13.77%. The company's healthcare services vertical reported revenue of ₹3,268 crore versus ₹2,822 crore in Q4FY25, representing 16% year-on-year growth. According to the company's exchange filing, the healthcare services segment achieved EBITDA of ₹781 crore with margins at 23.9% in Q4FY26, while PAT stood at ₹412 crore compared to ₹385 crore in Q4FY25, up 7% YoY. Apollo Health and Lifestyle also posted 24.2% revenue growth to ₹489.5 crore in the reporting quarter, while Apollo HealthCo registered revenue of ₹2,848.2 crore in Q4 FY26, marking 20% growth.
The board of directors recommended a final dividend of ₹10 per equity share (200% of face value of ₹5 per share) for FY26, subject to approval at the upcoming Annual General Meeting on August 25, 2026. According to reports from The Economic Times, the company has fixed August 14, 2026, as the record date to determine shareholder eligibility for the final dividend and AGM participation. The dividend, if declared, will be paid on or before September 10, 2026. At 10:45 AM, shares were trading at ₹8,233.5 apiece on the National Stock Exchange, gaining 1.92%.
The board approved the proposal for the merger of Apollo Hospitals North Limited (a wholly-owned subsidiary) into Apollo Hospitals Enterprise Ltd, subject to necessary statutory approvals. As reported by The Economic Times, the merger will be executed through the National Company Law Tribunal route in accordance with the Companies Act, 2013. Additionally, Apollo Health and Lifestyle Limited announced a combination for its Mother & Child and Fertility verticals with Kids Clinic India Limited's corresponding businesses under the Cloudnine brand. The proposed transaction values AHLL's standalone Mother & Child and Fertility verticals at ₹1,550 crore through cash and equity stake in the merged platform.
According to The Economic Times, Apollo Hospitals reported robust consolidated performance for FY26, with revenue rising 16% year-on-year to ₹25,229 crore compared with ₹21,794 crore in FY25. The company's EBITDA stood at ₹3,769 crore against ₹3,022 crore in the previous financial year, despite continued investments in Apollo 24/7, which incurred costs of ₹467 crore during FY26, including a non-cash ESOP charge of ₹118 crore. Reported profit after tax increased sharply to ₹1,942 crore from ₹1,446 crore in FY25, while diluted earnings per share came in at ₹134.95 for the year. Meanwhile, Apollo 24/7 recorded a gross merchandise value (GMV) of ₹2,037 crore, reflecting continued traction in the company's digital healthcare ecosystem.
